Insider Trading History of Quimi Daphne

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Quimi Daphne since 2014. This trader's CIK number is 1543031. At the time of last reporting, Quimi Daphne was the Director of Century Therapeutics, Inc.. (stock ticker symbol IPSC). Also see all insider trading activities at Century Therapeutics, Inc..

Note that in the past Quimi Daphne also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Century Therapeutics, Inc. (IPSC) by Quimi Daphne

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 IPSC 5,000 $7,655 0 $0 0 $0

Yearly summary of insider trading at Amylyx Pharmaceuticals, Inc. (AMLX) by Quimi Daphne

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 AMLX 5,000 $9,435 0 $0 0 $0

Yearly summary of insider trading at Amicus Therapeutics, Inc. (FOLD) by Quimi Daphne

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 FOLD 0 $0 11,923 $152,444 0 $0
2022 FOLD 0 $0 10,194 $109,140 0 $0
2021 FOLD 0 $0 0 $0 16,628 $48,886
2020 FOLD 0 $0 31,872 $445,848 82,215 $248,747
2018 FOLD 0 $0 24,899 $363,504 24,899 $203,769
2017 FOLD 0 $0 7,000 $99,743 7,000 $99,743
2016 FOLD 0 $0 8,546 $68,368 27,858 $22,864
2015 FOLD 0 $0 23,850 $310,613 38,850 $184,107
2014 FOLD 21,050 $141,153 21,050 $141,153 0 $0


Insider trading activities at 3 companies by Quimi Daphne:

1. Century Therapeutics, Inc. (IPSC)

2. Amylyx Pharmaceuticals, Inc. (AMLX)

3. Amicus Therapeutics, Inc. (FOLD)

Table 1. Insider trading of Century Therapeutics, Inc. (IPSC) by Quimi Daphne

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-09-12 IPSC Buy 5,000 1.53 7,655

Table 2. Insider trading of Amylyx Pharmaceuticals, Inc. (AMLX) by Quimi Daphne

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-05-14 AMLX Buy 2,750 1.89 5,183
2024-05-15 AMLX Buy 2,250 1.89 4,252

Table 3. Insider trading of Amicus Therapeutics, Inc. (FOLD) by Quimi Daphne

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-01-17 FOLD Sale 5,000 12.49 62,445
2023-01-18 FOLD Sale 6,923 13.00 89,999
2022-08-05 FOLD Sale 5,798 12.00 69,576
2022-06-17 FOLD Sale 4,396 9.00 39,564
2021-03-05 FOLD Option Ex 16,628 2.94 48,886
2020-12-21 FOLD Option Ex 5,000 2.94 14,700
2020-12-21 FOLD Sale 5,000 24.09 120,475
2020-12-15 FOLD Option Ex 30,321 3.33 100,817
2020-10-02 FOLD Option Ex 11,000 2.45 26,950
2020-10-01 FOLD Sale 5,000 14.02 70,100
2020-10-01 FOLD Option Ex 5,000 2.94 14,700
2020-07-01 FOLD Sale 6,872 15.47 106,323
2020-07-01 FOLD Option Ex 19,872 2.69 53,555
2020-01-09 FOLD Option Ex 11,022 3.45 38,025
2020-01-09 FOLD Sale 15,000 9.93 148,950
2018-03-09 FOLD Sale 8,750 15.00 131,250
2018-03-09 FOLD Option Ex 8,750 5.96 52,150
2018-03-01 FOLD Option Ex 8,149 4.16 33,899
2018-03-01 FOLD Sale 8,149 14.05 114,534
2018-01-02 FOLD Option Ex 8,000 14.71 117,720
2018-01-02 FOLD Sale 8,000 14.71 117,720
2017-10-12 FOLD Sale 7,000 14.25 99,743
2017-10-12 FOLD Option Ex 7,000 14.25 99,743
2016-11-09 FOLD Option Ex 2,858 8.00 22,864
2016-11-09 FOLD Sale 8,546 8.00 68,368
2016-01-04 FOLD Option Ex 25,000 .00 0
2015-10-01 FOLD Option Ex 11,250 13.13 147,757
2015-10-01 FOLD Sale 11,250 13.13 147,757
2015-09-14 FOLD Sale 2,500 18.08 45,199
2015-07-01 FOLD Option Ex 2,600 13.98 36,350
2015-07-01 FOLD Sale 2,600 13.98 36,350
2015-05-08 FOLD Option Ex 25,000 .00 0
2015-05-11 FOLD Sale 7,500 10.84 81,307
2014-11-25 FOLD Sale 3,500 8.00 28,000
2014-11-25 FOLD Buy 3,500 8.00 28,000
2014-10-03 FOLD Buy 6,812 7.00 47,684
2014-10-03 FOLD Sale 6,812 7.00 47,684
2014-09-29 FOLD Buy 10,738 6.10 65,469
2014-09-29 FOLD Sale 10,738 6.10 65,469

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Quimi Daphne (Director of Century Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.